Preeti Kabra
About Preeti Kabra
Data last updated:
Preeti Kabra is a Director at Medpace Clinical Research India Private Limited (since 2023) and Designated Partner at Tatva Techno Ventures Llp (since 2015). The companies operate in Pharma and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹19.34 Cr; the largest is Medpace Clinical Research India Private Limited at ₹19.34 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medpace Clinical Research India Private Limited U24232MH2007PTC338993 | Director | 26 Apr 2023 | 2007 | ₹19.34 Cr (FY 2025) | Active |
 Tatva Techno Ventures Llp AAE-1700 | Designated Partner | 15 Jun 2015 | 2015 | ₹24,979 (FY 2021) | Active |
Board colleagues of Preeti Kabra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jesse Jacob Geiger | 08936155 | Medpace Clinical Research India Private Limited | Director |
| Stephen Paul Ewald | 08936156 | Medpace Clinical Research India Private Limited | Director |
| Shamender Sharma | 06438939 | Tatva Techno Ventures Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Preeti Kabra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Preeti Kabra
Preeti Kabra currently holds 2 directorships: Medpace Clinical Research India Private Limited (Director, since 26 Apr 2023, revenue ₹19.34 Cr (FY 2025)); Tatva Techno Ventures Llp (Designated Partner, since 15 Jun 2015, revenue ₹24,979 (FY 2021)).
Preeti Kabra was first appointed on 15 Jun 2015 as Designated Partner at Tatva Techno Ventures Llp. The most recent appointment on record is 26 Apr 2023 at Medpace Clinical Research India Private Limited.
The 2 current companies of Preeti Kabra that report revenue have a combined latest revenue of ₹19.34 Cr: Medpace Clinical Research India Private Limited ₹19.34 Cr (FY 2025); Tatva Techno Ventures Llp ₹24,979 (FY 2021).
The current boards of Preeti Kabra's companies include Jesse Jacob Geiger (Medpace Clinical Research India Private Limited), Stephen Paul Ewald (Medpace Clinical Research India Private Limited), Shamender Sharma (Tatva Techno Ventures Llp).